Spotlights

Patent

The patent application is now officially registered! We are thrilled to announce that AUXESIS PHARMA HOLDING AB (publ) has successfully submitted the application for its

Read More »

Östersund

Production site AUXESIS PHARMA HOLDING AB (publ) continues its “journey” by visiting the Business Office in Östersund Municipality on Friday 2023-10-27. In addition, Region Jämtland/Härjedalen

Read More »

Euroclear

AUXESIS PHARMA HOLDING AB (publ) is now a settlement company and started with Euroclear as the securities institution. This is the last phase (according to

Read More »

Production Site

Ostersund AUXESIS PHARMA HOLDING AB (publ) is in the establishment phase of pharmaceutical manufacturing in Östersund, Sweden.  In September 2023 the company will submit an

Read More »

Protocol AGM 2023

Protocol from The AUXESIS PHARMA HOLDING AB (publ) Annual General Meeting 2023 is now available for download in the Investor Hub.

Read More »

Annual report

AUXESIS PHARMA HOLDING (publ) Annual report /Årsredovisning and associated documents regarding the Annual Meeting is now available for download in the Investor Hub for investors.

Read More »

Pitch update

New updated Pitch, Memorandum and Scenario Valuation 2023 for download. Auxesis Pharma Pitch 2023 Download here Auxesis Pharma Memorandum 2023 Download here Auxesis Pharma Scenario

Read More »